Kohlberg Kravis Roberts & Co’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-104,498	Closed	-$1.03M	–	199
2022 Q3	$1.03M	Hold	104,498	–	–	0.02%	113
2022 Q2	$1.03M	Hold	104,498	–	–	0.01%	133
2022 Q1	$1.02M	Buy	104,498 +67,067	+179%	+$654K	0.01%	145
2021 Q4	$367K	Buy	37,431 +6,342	+20%	+$61.9K	﹤0.01%	144
2021 Q3	$302K	Buy	+31,089	New	+$301K	﹤0.01%	147

Kohlberg Kravis Roberts & Co's SHAC Position: Q4 2022 in Review

Kohlberg Kravis Roberts & Co sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 104,498 shares — an estimated $1.03M sold.

Kohlberg Kravis Roberts & Co first reported a position in SHAC in Q3 2021 and held it in 5 quarters. The position peaked at $1.03M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Kohlberg Kravis Roberts & Co reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Kohlberg Kravis Roberts & Co sold 104,498 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $1.03M.
Kohlberg Kravis Roberts & Co first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q3 2021 and held it in 5 quarters.
Kohlberg Kravis Roberts & Co's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $1.03M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q4 2022, filed 14 Feb 2023.